A Randomized, Double-Blind, Placebo Controlled, Multi - Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514520-16-00

Acronym

LIV001-02

Enrollment

Registered

2024-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild-to-moderate active ulcerative colitis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026